Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine with propofol/etomidate mixture for gastroscopy sedation
ChiCTR2000032083Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital, Southern Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, propofol and etomidate (5 arms), sponsored by Shunde Hospital, Southern Medical University. Primary endpoints: Dose of propofol/etomidate mixture used and ED50 of propofol/etomidate mixture. Planned start May 2020; status: not yet recruiting.
02
Drugs
esketaminepropofoletomidate
Beyond the preview
Go deeper on ChiCTR2000032083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032083.